40
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Molecular evaluation of renal biopsies: a search for predictive and prognostic markers in lupus nephritis

&
Pages 561-565 | Published online: 09 Jan 2014

References

  • Bomback AS, Appel GB. Updates on the treatment of lupus nephritis. J. Am. Soc. Nephrol.21(12), 2028–2035 (2010).
  • Valesini G, Conti F. The persistent challenge of lupus nephritis. Clin. Rev. Allergy Immunol.40(3), 135–137 (2011).
  • Esdaile JM, Joseph L, Mackenzie T, Kashgarian M, Hayslett JP. The benefit of early treatment with immunosuppressive agents in lupus nephritis. J. Rheumatol.21(11), 2046–2051 (1994).
  • Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J. Rheumatol.33(8), 1563–1569 (2006).
  • Rovin BH, Zhang X. Biomarkers for lupus nephritis: the quest continues. Clin. J. Am. Soc. Nephrol.4(11), 1858–1865 (2009).
  • Houssiau FA, Vasconcelos C, D’cruz D et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum.50(12), 3934–3940 (2004).
  • Reich HN, Landolt-Marticorena C, Boutros PC et al. Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis. J. Mol. Diagn.13(2), 143–151 (2010).
  • Cohen CD, Grone HJ, Grone EF, Nelson PJ, Schlondorff D, Kretzler M. Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int.61(1), 125–132 (2002).
  • Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J. Am. Soc. Nephrol.14(11), 2958–2966 (2003).
  • Tamura M, Aizawa R, Hori M, Ozaki H. Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model. Histochem. Cell Biol.131(4), 483–490 (2009).
  • Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol.28(2), 123–136 (1996).
  • Page-Mccaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol.8(3), 221–233 (2007).
  • Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell111(5), 635–646 (2002).
  • Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol.4(8), 617–629 (2004).
  • Dunsmore SE, Saarialho-Kere UK, Roby JD et al. Matrilysin expression and function in airway epithelium. J. Clin. Invest.102(7), 1321–1331 (1998).
  • Jovanovic V, Dugast AS, Heslan JM et al. Implication of matrix metalloproteinase 7 and the noncanonical wingless-type signaling pathway in a model of kidney allograft tolerance induced by the administration of anti-donor class II antibodies. J. Immunol.180(3), 1317–1325 (2008).
  • Von Toerne C, Schmidt C, Adams J et al. Wnt pathway regulation in chronic renal allograft damage. Am. J. Transplant.9(10), 2223–2239 (2009).
  • Rodder S, Scherer A, Korner M et al. Meta-analyzes qualify metzincins and related genes as acute rejection markers in renal transplant patients. Am. J. Transplant.10(2), 286–297 (2010).
  • Lautrette A, Li S, Alili R et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat. Med.11(8), 867–874 (2005).
  • Terzi F, Burtin M, Hekmati M et al. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J. Clin. Invest.106(2), 225–234 (2000).
  • Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int.36(5), 891–896 (1989).
  • Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR. Tubulointerstitial inflammation and scarring predict outcome in lupus nephritis. Arthritis Care Res. DOI: 10.1002/acr.20441 (2011) (Epub ahead of print).
  • Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak TJ. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum.33(7), 970–977 (1990).
  • Valeri A, Radhakrishnan J, Estes D et al. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Clin. Nephrol.42(2), 71–78 (1994).
  • Ponticelli C, Moroni G. Flares in lupus nephritis: incidence, impact on renal survival and management. Lupus7(9), 635–638 (1998).
  • Madaio MP. Renal biopsy. Kidney Int.38(3), 529–543 (1990).
  • Kretzler M, Cohen CD, Doran P et al. Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J. Am. Soc. Nephrol.13(7), 1961–1972 (2002).
  • Higgins JP, Wang L, Kambham N et al. Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol. Biol. Cell15(2), 649–656 (2004).
  • Whiting-O’Keefe Q, Henke JE, Shearn MA, Hopper J Jr, Biava CG, Epstein WV. The information content from renal biopsy in systemic lupus erythematosus. Ann. Intern. Med.96(6 Pt 1), 718–723 (1982).
  • Bach D, Hanraths M, Grabensee B. Ultrasonic-guided percutaneous renal biopsy in patients with renal insufficiency. Ultraschall. Med.8(3), 149–151 (1987).
  • Kohda Y, Murakami H, Moe OW, Star RA. Analysis of segmental renal gene expression by laser capture microdissection. Kidney Int.57(1), 321–331 (2000).
  • White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: a stepping stone towards improved cancer management. Nat. Rev. Clin. Oncol.8(2), 75–84 (2010).
  • Akkina S, Becker BN. MicroRNAs in kidney function and disease. Transl. Res.157(4), 236–240 (2011).
  • Li JY, Yong TY, Michael MZ, Gleadle JM. Review: the role of microRNAs in kidney disease. Nephrology (Carlton)15(6), 599–608 (2010).
  • Liang M, Liu Y, Mladinov D et al. MicroRNA: a new frontier in kidney and blood pressure research. Am. J. Physiol. Renal Physiol.297(3), F553–F558 (2009).
  • Tian Z, Greene AS, Pietrusz JL, Matus IR, Liang M. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res.18(3), 404–411 (2008).
  • Sun Y, Koo S, White N et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res.32(22), e188 (2004).
  • Zhou H, Cheruvanky A, Hu X et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int.74(5), 613–621 (2008).
  • Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol. Int.29(7), 749–754 (2009).
  • Te JL, Dozmorov IM, Guthridge JM et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One5(5), e10344 (2010).
  • Bentwich I, Avniel A, Karov Y et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet.37(7), 766–770 (2005).
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116(2), 281–297 (2004).
  • Krutzfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature438(7068), 685–689 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.